
    
      Phase III, non inferiority, multicentric, controlled, single blind, parallel-group,
      randomized study.

      Population: 224 patients with external otitis , men and women aged between 1 - 70 years.

      Primary endpoint: The primary endpoint of this study is the elimination of pain, swelling and
      otorrhea (cure).

      Secondary endpoint: The endpoint will be the identification of the side effects of medication
      use.
    
  